AMGN vs RVTY
By Alex · Tickerpine
Amgen Inc. vs Revvity, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | AMGN | RVTY |
|---|---|---|
| Price | $358.33 | $113.02 |
| Market cap | $193.39B | $12.61B |
| P/E ratio | 24.9 | 54.3 |
| ROE | 101.32% | 3.23% |
| Profit margin | 20.96% | 8.26% |
| Revenue growth | 5.80% | 7.00% |
| Dividend yield | 2.81% | 0.25% |
| Beta | 0.42 | 1.11 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
AMGN vs RVTY in plain English
- AMGN is the bigger company — about 15.3× the market cap of RVTY.
- AMGN is cheaper on earnings (P/E 24.9 vs 54.3).
- AMGN earns a higher return on equity (101% vs 3%).
- RVTY is growing revenue faster (7% vs 6%).
- AMGN has the higher dividend yield (2.81% vs 0.25%).
How would $1,000 have done in each?
AMGN return calculator
See what $1,000 in Amgen Inc. would be worth today.
RVTY return calculator
See what $1,000 in Revvity, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.